MAPS Founder and Executive Director Rick Doblin, Ph.D., joins Dr. Drew Pinsky on The Dr. Drew Podcast to discuss the results of MAPS’ first Phase 3 trial of MDMA-assisted therapy for PTSD, our strategic approach of studying MDMA-assisted therapy in clinical trials, and the growing field of psychedelic research. Listen to the episode!
Originally appearing here.
Today Drew is joined by Dr. Rick Doblin, Executive Director Multidisciplinary Association for Psychedelic Studies (MAPS). Drew and Dr. Doblin discuss some exciting research being done right now regarding MDMA-assisted therapy and much more, learn more about Dr. Rick Doblin at maps.org.